©2005SHENZHENBUREAUOFSCIENCE,TECHNOLOGY&INFORMATION2020/1/25深圳生物医药产业投资环境与发展规划深圳市科技和信息局ShenzhenBureauofScience,Technology&InformationJan.20,2006中国生命科学高峰论坛ChinaLifeSciencesPartneringForum--ShenzhenInvestmentenvironmentanddevelopmentplanningforShenzhenBiomedicineIndustry©2005SHENZHENBUREAUOFSCIENCE,TECHNOLOGY&INFORMATION2内容提要Content深圳市生物医药产业发展的历史回顾ReviewofthedevelopmentofShenzhen’sbiomedicineindustry深圳市生物医药产业腾飞的现实机遇PresentopportunityforrapiddevelopmentofShenzhen’sbiomedicineindustry深圳市生物医药“十一五”期间发展目标DevelopmentobjectiveofShenzhen’sbiomedicineduringtheperiodof“EleventhFive-YearPlan”深圳市生物医药“十一五”规划四大重点支持领域keysupportfieldsforShenzhen’sbiomedicineduringthe“EleventhFive-YearPlan”planning深圳市发展生物医药产业的工作重点KeypointsfordevelopingShenzhen’sbiomedicineindustry©2005SHENZHENBUREAUOFSCIENCE,TECHNOLOGY&INFORMATION3深圳市生物医药产业发展的历史回顾一Review1ofthedevelopmentofShenzhen’sbiomedicineindustry十五期间深圳生物医药产业已形成良好的产业基础Shenzhen’sbiomedicineindustryhasformedafineindustrialfoundationduringtheperiodof“TenthFive-YearPlan”2003年产值位居全国大中城市第3位;Outputvaluein2003ranked3rdamongChina’sbigandmediumcities.2004年产值170.1亿元其中药品(含部分保健品)129亿元,较上年增长14%,医疗器械产品41亿元,较上年增长54%;Outputvaluein2004was17.01billionyuan,thereintomedicine(includinghealthproducts)are12.9billion,upby14%overthepreviousyear;medicalinstruments,upby54%overthepreviousyear;E.g.:SanofiAventis,Siemens,JincunPharmacy,Olympus,AvailMedicalProducts,Inc.andPerkinElmer;E.g.:999,Joincare,Mindray,Neptunus,Accord,Kexing,KangtaiandShangrong.©2005SHENZHENBUREAUOFSCIENCE,TECHNOLOGY&INFORMATION4深圳市生物医药产业发展的历史回顾一Review1ofthedevelopmentofShenzhen’sbiomedicineindustry一批跨国生物企业在深建有生产基地Abatchofmulti-nationalbiologyenterpriseshavesetupproductionbasesatShenzhen;如:赛诺菲安万特(sanofiaventis)、西门子、津村药业、奥林巴斯、美国安卫医仪、珀金-埃尔默等E.g.:SanofiAventis,Siemens,JincunPharmacy,Olympus,AvailMedicalProducts,Inc.andPerkinElmer;十五期间深圳生物医药产业已形成良好的产业基础Shenzhen’sbiomedicineindustryhasformedafineindustrialfoundationduringtheperiodof“TenthFive-YearPlan”©2005SHENZHENBUREAUOFSCIENCE,TECHNOLOGY&INFORMATION5深圳市生物医药产业发展的历史回顾一Review1ofthedevelopmentofShenzhen’sbiomedicineindustry一批本土企业成长为深圳乃至国内本领域龙头AbatchoflocalenterpriseshavebecometheleaderofthesectoratShenzhenandeveninChinaaswell;如:三九、健康元、迈瑞、海王、一致、科兴、康泰、尚荣等E.g.:999,Joincare,Mindray,Neptunus,Accord,Kexing,KangtaiandShangrong.十五期间深圳生物医药产业已形成良好的产业基础Shenzhen’sbiomedicineindustryhasformedafineindustrialfoundationduringtheperiodof“TenthFive-YearPlan”©2005SHENZHENBUREAUOFSCIENCE,TECHNOLOGY&INFORMATION6深圳市生物医药产业发展的历史回顾二Review2ofthedevelopmentofShenzhen’sbiomedicineindustry主体明确:初步形成了以市场为导向、以产业化为核心、以企业为主体、以国内大学和研究机构为依托的技术创新体系,拥有一批与国际技术水准接轨、按现代企业制度管理和运营的生物医药研发企业Definiteobjective:atechnicalcreationsystemhasbasicallyformedwiththemarketasorientation,industrializationasthecore,enterprisesasthemainbody,domesticuniversitiesandresearchinstitutesasthesupport.ThereisabatchofbiomedicineR&Denterpriseswithinternationalstandardtechnology,andmanagingandoperatingaccordingtomoderncorporatesystem.如:赛百诺、微芯生物、翰宇生物、海普瑞等E.g.:Sibiono,Chipscreen,HybioandHepalink自主创新春苗出土Emergenceofself-creation©2005SHENZHENBUREAUOFSCIENCE,TECHNOLOGY&INFORMATION7深圳市生物医药产业发展的历史回顾二Review2ofthedevelopmentofShenzhen’sbiomedicineindustry人才汇聚:拥有了一批具有创新精神的生物产业高级人才Gatheringoftalents:Lotsofseniorspecialistswithcreationspiritengagedinbiologyindustry成果累累:世界第一个基因治疗药物、中国第一个生物工程一类新药、中国第一台全自动生化分析仪、中国第一台医用核磁共振诊断仪、中国第一台彩色B超等Richfruits:world’sfirstgenecuringmedicine,China’sfirstclass-onebioengineeringmedicine,China’sfirstautobiochemicalanalyzer,China’sfirstmedicalnuclearmagneticresonancediagnosisinstrumentandChina’sfirstB-typecolorultrasonicinstrument,etc自主创新春苗出土Emergenceofself-creation©2005SHENZHENBUREAUOFSCIENCE,TECHNOLOGY&INFORMATION8深圳市生物医药产业发展的历史回顾三Review3ofthedevelopmentofShenzhen’sbiomedicineindustry2005年6月5日,国家发改委正式认定深圳为首批三个国家生物产业基地之一。On5June,2005,theNationalDevelopmentandReformCommissionofficiallyaffirmedShenzhenasoneofthe3citiesinthefirstbatchoftheStatebiomedicineproductionbase.第一批国家生物产业基地布点城市OneofthebasecitiesinthefirstbatchoftheStatebiomedicineindustrialization©2005SHENZHENBUREAUOFSCIENCE,TECHNOLOGY&INFORMATION9深圳市生物医药产业发展的历史回顾三Review3ofthedevelopmentofShenzhen’sbiomedicineindustry第一批国家生物产业基地布点城市OneofthebasecitiesinthefirstbatchoftheStatebiomedicineindustrialization定位:依托深圳现有的生物医药产业基础,发挥大型企业集中、国际化程度高和市场环境相对完善的优势,促进产业集聚,实现规模效应,推进大型生物医药企业集团和中小企业群建设,提高生物医药产业的国际竞争力,带动区域产业结构优化升级,努力将深圳建成世界重要的生物医药研发、生产和出口基地之一。Positioning:OnthebasisofShenzhen’scurrentbiomedicineindustry,bringingtheadvantagesofthelargeenterprisesonhighdegreeofconcentrationandinternationalizationanrelativelycompletemarketenvironmentintofullplay,promoteindustrialgathering,realizescaledeffect,pushforwardtheconstructionoflargebiomedicinegroupandmediumandsmallenterprises,enhanceinternationalcompetitivenessofthebiomedicineindustry,promoteoptimizationandupdateoftheregionalindustrialstructure,strivetobuildShenzhenintooneoftheworldimportantR&D,productionandexportbasesforbiomedicines.©2005SHENZHENBUREAUOFSCIENCE,TECHNOLOGY&INFORMATION10深圳市生物医药产业腾飞的现实机遇一Presentopportunity(1)forrapiddevelopmentofSh